Patent · US Active

Methods of treating advanced prostate cancer

US10603328B2 · kind B2 · utility

1Cited by
1References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2018
Grant dateMar 31, 2020
Priority date
Expiry dateApr 30, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2300/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods for treating metastatic prostate cancer using anti-androgen compounds and radionuclide-labeled androgens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.